Published in Mod Pathol on January 08, 2016
Metastatic Merkel cell carcinoma response to nivolumab. J Immunother Cancer (2016) 1.40
Genomic portfolio of Merkel cell carcinoma as determined by comprehensive genomic profiling: implications for targeted therapeutics. Oncotarget (2016) 0.78
Merkel cell polyomavirus and Merkel cell carcinoma. Philos Trans R Soc Lond B Biol Sci (2017) 0.76
Next-Generation Sequencing in Oncology: Genetic Diagnosis, Risk Prediction and Cancer Classification. Int J Mol Sci (2017) 0.75
Merkel Cell Carcinoma of the Head and Neck: Recommendations for Diagnostics and Treatment. Ann Surg Oncol (2017) 0.75
An integrated map of genetic variation from 1,092 human genomes. Nature (2012) 59.82
Clonal integration of a polyomavirus in human Merkel cell carcinoma. Science (2008) 16.60
A landscape of driver mutations in melanoma. Cell (2012) 12.61
Analysis of 6,515 exomes reveals the recent origin of most human protein-coding variants. Nature (2012) 8.91
Tobacco smoke carcinogens, DNA damage and p53 mutations in smoking-associated cancers. Oncogene (2002) 7.04
EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations. Nature (2012) 7.01
Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer. Nat Genet (2012) 5.28
T antigen mutations are a human tumor-specific signature for Merkel cell polyomavirus. Proc Natl Acad Sci U S A (2008) 4.74
Comprehensive genomic analysis identifies SOX2 as a frequently amplified gene in small-cell lung cancer. Nat Genet (2012) 4.70
Germline BAP1 mutations predispose to malignant mesothelioma. Nat Genet (2011) 4.26
Germline mutations in BAP1 predispose to melanocytic tumors. Nat Genet (2011) 3.91
Cytokeratin 20 in human carcinomas. A new histodiagnostic marker detected by monoclonal antibodies. Am J Pathol (1992) 3.43
Tumor evolution. High burden and pervasive positive selection of somatic mutations in normal human skin. Science (2015) 3.29
Merkel cell polyomavirus expression in merkel cell carcinomas and its absence in combined tumors and pulmonary neuroendocrine carcinomas. Am J Surg Pathol (2009) 1.79
UV signature mutations. Photochem Photobiol (2014) 1.52
EZH2 codon 641 mutations are common in BCL2-rearranged germinal center B cell lymphomas. PLoS One (2011) 1.49
Merkel cell carcinoma: a virus-induced human cancer. Annu Rev Pathol (2011) 1.46
Activation of PI3K signaling in Merkel cell carcinoma. Clin Cancer Res (2012) 1.45
Merkel cell polyomavirus infection, large T antigen, retinoblastoma protein and outcome in Merkel cell carcinoma. Clin Cancer Res (2011) 1.44
Array-CGH reveals recurrent genomic changes in Merkel cell carcinoma including amplification of L-Myc. J Invest Dermatol (2008) 1.42
Merkel cell carcinoma subgroups by Merkel cell polyomavirus DNA relative abundance and oncogene expression. Int J Cancer (2010) 1.42
Tumours associated with BAP1 mutations. Pathology (2013) 1.35
Immunohistochemical distinction between merkel cell carcinoma and small cell carcinoma of the lung. Am J Dermatopathol (2006) 1.31
EZH2: not EZHY (easy) to deal. Mol Cancer Res (2014) 1.20
Small cell carcinoma of the major salivary glands: clinicopathologic study with emphasis on cytokeratin 20 immunoreactivity and clinical outcome. Am J Surg Pathol (2004) 1.19
Translational implications of tumor heterogeneity. Clin Cancer Res (2015) 1.12
The Ten-Eleven Translocation-2 (TET2) gene in hematopoiesis and hematopoietic diseases. Leukemia (2013) 1.11
Merkel cell carcinoma: review. Adv Anat Pathol (2009) 1.09
Tumor evolution and progression in multifocal and paired non-invasive/invasive urothelial carcinoma. Virchows Arch (2014) 1.07
Cytokeratin 20-negative Merkel cell carcinoma is infrequently associated with the Merkel cell polyomavirus. Mod Pathol (2014) 1.07
The Distinctive Mutational Spectra of Polyomavirus-Negative Merkel Cell Carcinoma. Cancer Res (2015) 1.07
Merkel cell polyomavirus small T antigen is oncogenic in transgenic mice. J Invest Dermatol (2014) 1.03
Retinoblastoma gene mutations detected by whole exome sequencing of Merkel cell carcinoma. Mod Pathol (2014) 1.01
Merkel cell carcinoma with cytokeratin 20-negative and thyroid transcription factor-1-positive immunostaining admixed with squamous cell carcinoma. J Dermatol Sci (2011) 1.00
Identification of a melanoma susceptibility locus and somatic mutation in TET2. Carcinogenesis (2014) 0.98
Immunohistochemistry for Merkel cell polyomavirus is highly specific but not sensitive for the diagnosis of Merkel cell carcinoma in the Australian population. Hum Pathol (2011) 0.96
Analysis of thyroid transcription factor-1 and cytokeratin 20 separates merkel cell carcinoma from small cell carcinoma of lung. J Cutan Pathol (2000) 0.95
Merkel cell carcinoma: histopathologic and prognostic features according to the immunohistochemical expression of Merkel cell polyomavirus large T antigen correlated with viral load. Hum Pathol (2014) 0.93
Large T and small T antigens of Merkel cell polyomavirus. Curr Opin Virol (2015) 0.93
Small cell carcinoma in the parotid harboring Merkel cell polyomavirus. Oral Surg Oral Med Oral Pathol Oral Radiol (2014) 0.91
Mutation signatures of carcinogen exposure: genome-wide detection and new opportunities for cancer prevention. Genome Med (2014) 0.89
Tumorigenic activity of merkel cell polyomavirus T antigens expressed in the stratified epithelium of mice. Cancer Res (2015) 0.89
The spectrum of Merkel cell polyomavirus expression in Merkel cell carcinoma, in a variety of cutaneous neoplasms, and in neuroendocrine carcinomas from different anatomical sites. Hum Pathol (2011) 0.85
Merkel cell carcinoma dependence on bcl-2 family members for survival. J Invest Dermatol (2014) 0.84
Cutaneous squamous and neuroendocrine carcinoma: genetically and immunohistochemically different from Merkel cell carcinoma. Mod Pathol (2015) 0.80
Loss of cytokeratin 20 and acquisition of thyroid transcription factor-1 expression in a merkel cell carcinoma metastasis to the brain. Am J Dermatopathol (2014) 0.79
Cutaneous basal cell carcinosarcomas: evidence of clonality and recurrent chromosomal losses. Hum Pathol (2015) 0.78
Expression of focal TTF-1 expression in a case of CK7/CK20-positive Merkel cell carcinoma. J Cutan Pathol (2013) 0.77
Characterization of FN1-FGFR1 and novel FN1-FGF1 fusion genes in a large series of phosphaturic mesenchymal tumors. Mod Pathol (2016) 0.91
USP6 activation in nodular fasciitis by promoter-swapping gene fusions. Mod Pathol (2017) 0.75
Phenotypic and molecular differences between giant cell tumor of soft tissue and its bone counterpart. Histopathology (2017) 0.75
Ossifying fibromyxoid tumor: a clinicopathologic analysis of 26 subcutaneous tumors with emphasis on differential diagnosis and prognostic factors. J Cutan Pathol (2015) 0.75